BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  ASCO15: Oncothyreon Inc. Announces Presentation Of Positive ONT-380 Data In HER2-Positive Breast Cancer At ASCO Annual Meeting And Updates Development Plan

  June 1, 2015

   · 

  6 min read
• Drug Development

  Array BioPharma, Inc. Release: Binimetinib And Encorafenib Combination Shows Promising Clinical Activity And Potential Differentiated Safety In BRAF-Mutant Melanoma

  June 1, 2015

   · 

  6 min read
• Drug Development

  ASCO15: Adaptimmune Announces Data From Clinical Studies Of NY-ESO-1 Specific T-Cells In Multiple Cancers At The 2015 Annual ASCO Meeting

  June 1, 2015

   · 

  7 min read
• FDA

  Upsher-Smith Laboratories Release: FDA Approves Expanded Indication For Qudexy XR (Topiramate) Extended-Release Capsules Within The Pediatric Population

  June 1, 2015

   · 

  9 min read
• Resverlogix Presents New Data At 52nd Annual European Renal Association - European Dialysis & Transplant Association Congress (ERA-EDTA)

  June 1, 2015

   · 

  5 min read
• Drug Development

  ARMO BioSciences Announces Efficacy And Safety Data For Immuno-Oncology Program With Novel Mechanism Of Action

  June 1, 2015

   · 

  3 min read
• Drug Development

  ASCO15: Celldex Release: Randomized Phase 2 React Study Of RINTEGA In Recurrent Bevacizumab-Naive Glioblastoma Demonstrates Statistically Significant Overall Survival And Emergence Of Long-Term Survival Benefit; Primary Endpoint Of PFS6 Met

  June 1, 2015

   · 

  12 min read
• Drug Development

  Exelixis Announces Positive Results From Phase 2 Investigator-Sponsored Trial Of Cabozantinib In RET-Rearranged Non-Small Cell Lung Cancers

  June 1, 2015

   · 

  9 min read
• Genetown

  Tesaro, Inc. Announces Successful Completion Of Rolapitant Bioequivalence Study

  June 1, 2015

   · 

  3 min read
• Business

  Baxter International Launches a Vitesse Biologics in South San Francisco

  June 1, 2015

   · 

  7 min read